Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,622 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II clinical study of the combination chemotherapy regimen of irinotecan plus oral etoposide for the treatment of recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 101 Group Study).
Shoji T, Takatori E, Omi H, Kumagai S, Yoshizaki A, Yokoyama Y, Mizunuma H, Fujimoto T, Takano T, Yaegashi N, Tase T, Nakahara K, Kurachi H, Nishiyama H, Sugiyama T. Shoji T, et al. Among authors: yokoyama y. Int J Gynecol Cancer. 2011 Jan;21(1):44-50. doi: 10.1097/IGC.0b013e3181ffbe9f. Int J Gynecol Cancer. 2011. PMID: 21330830 Clinical Trial.
A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).
Shoji T, Takatori E, Kaido Y, Omi H, Yokoyama Y, Mizunuma H, Kaiho M, Otsuki T, Takano T, Yaegashi N, Nishiyama H, Fujimori K, Sugiyama T. Shoji T, et al. Among authors: yokoyama y. Cancer Chemother Pharmacol. 2014 May;73(5):895-901. doi: 10.1007/s00280-014-2418-8. Epub 2014 Mar 1. Cancer Chemother Pharmacol. 2014. PMID: 24585045 Free PMC article. Clinical Trial.
Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study.
Kagabu M, Shoji T, Murakami K, Omi H, Honda T, Miura F, Yokoyama Y, Tokunaga H, Takano T, Ohta T, Shimizu D, Sato N, Soeda S, Watanabe T, Yamada H, Mizunuma H, Yaegashi N, Nagase S, Tase T, Sugiyama T. Kagabu M, et al. Among authors: yokoyama y. Int J Clin Oncol. 2016 Aug;21(4):735-740. doi: 10.1007/s10147-016-0946-4. Epub 2016 Jan 19. Int J Clin Oncol. 2016. PMID: 26782958
A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).
Shoji T, Takatori E, Omi H, Kagabu M, Honda T, Futagami M, Yokoyama Y, Kaiho M, Tokunaga H, Otsuki T, Takano T, Yaegashi N, Kojimahara T, Ohta T, Nagase S, Soeda S, Watanebe T, Nishiyama H, Sugiyama T. Shoji T, et al. Among authors: yokoyama y. Cancer Chemother Pharmacol. 2017 Aug;80(2):355-361. doi: 10.1007/s00280-017-3363-0. Epub 2017 Jun 27. Cancer Chemother Pharmacol. 2017. PMID: 28656383 Free PMC article. Clinical Trial.
Advanced squamous cell carcinomas arising from mature cystic teratoma of the ovary: a retrospective case series at the Tohoku Gynecologic Cancer Unit.
Tokunaga H, Watanabe Y, Kaiho M, Yokoyama Y, Futagami M, Watanabe T, Soeda S, Takatori E, Shoji T, Niikura H, Nishigori H, Takahashi F, Sugiyama T, Yaegashi N. Tokunaga H, et al. Among authors: yokoyama y. Int Cancer Conf J. 2016 Mar 17;5(3):146-149. doi: 10.1007/s13691-016-0246-x. eCollection 2016 Jul. Int Cancer Conf J. 2016. PMID: 31149443 Free PMC article.
Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study).
Shoji T, Takatori E, Nagasawa T, Kagabu M, Baba T, Shigeto T, Matsumura Y, Shimizu D, Terada Y, Seino M, Ohta T, Nagase S, Shigeta S, Tokunaga H, Shimada M, Kaiho-Sakuma M, Furukawa S, Soeda S, Watanabe T, Takahashi F, Yokoyama Y. Shoji T, et al. Among authors: yokoyama y. Int J Clin Oncol. 2022 Dec;27(12):1874-1880. doi: 10.1007/s10147-022-02246-1. Epub 2022 Oct 10. Int J Clin Oncol. 2022. PMID: 36214925
A case of small cell carcinoma of the vagina.
Tamura R, Yokoyama Y, Kobayashi A, Osawa Y, Shigeto T, Futagami M, Mizunuma H. Tamura R, et al. Among authors: yokoyama y. Rare Tumors. 2013 Dec 5;5(4):e58. doi: 10.4081/rt.2013.e58. eCollection 2013. Rare Tumors. 2013. PMID: 24416492 Free PMC article.
2,622 results